[1]
Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Annals of surgery. 2010 Sep:252(3):426-32; discussion 432-3. doi: 10.1097/SLA.0b013e3181f08f32. Epub
[PubMed PMID: 20739842]
Level 1 (high-level) evidence
[2]
Pilewskie M, Jochelson M, Gooch JC, Patil S, Stempel M, Morrow M. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? Journal of the American College of Surgeons. 2016 Feb:222(2):138-45. doi: 10.1016/j.jamcollsurg.2015.11.013. Epub 2015 Nov 25
[PubMed PMID: 26711795]
[3]
Lim GH, Upadhyaya VS, Acosta HA, Lim JMA, Allen JC Jr, Leong LCH. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Jul:44(7):945-950. doi: 10.1016/j.ejso.2018.04.003. Epub 2018 Apr 12
[PubMed PMID: 29705286]
[4]
Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, Spano G, Luini A, Intra M, Veronesi P, Berrettini A, Paganelli G. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Mar:18(3):473-8
[PubMed PMID: 17164229]
Level 2 (mid-level) evidence
[5]
Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance for Clinical Trials in Oncology. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 9:310(14):1455-61. doi: 10.1001/jama.2013.278932. Epub
[PubMed PMID: 24101169]
[6]
Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Annals of surgical oncology. 2007 Sep:14(9):2477-84
[PubMed PMID: 17587091]
[7]
Gentilini O, Veronesi P, Botteri E, Soggiu F, Trifirò G, Lissidini G, Galimberti V, Musmeci S, Raviele PR, Toesca A, Ratini S, Del Castillo A, Colleoni M, Talakhadze N, Rotmensz N, Viale G, Veronesi U, Luini A. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution. Annals of surgical oncology. 2011 Oct:18(10):2879-84. doi: 10.1245/s10434-011-1694-3. Epub 2011 Apr 9
[PubMed PMID: 21479691]
[8]
Liang Y, Chen X, Tong Y, Zhan W, Zhu Y, Wu J, Huang O, He J, Zhu L, Li Y, Chen W, Shen K. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era. World journal of surgical oncology. 2019 Feb 20:17(1):37. doi: 10.1186/s12957-019-1582-z. Epub 2019 Feb 20
[PubMed PMID: 30786903]
[9]
Jorns JM, Kidwell KM. Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection. American journal of clinical pathology. 2016 Jul:146(1):57-66. doi: 10.1093/ajcp/aqw078. Epub 2016 Jul 3
[PubMed PMID: 27373347]
[10]
Joyce DP, Lowery AJ, McGrath-Soo LB, Downey E, Kelly L, O'Donoghue GT, Barry M, Hill AD. Management of the axilla: has Z0011 had an impact? Irish journal of medical science. 2016 Feb:185(1):145-9. doi: 10.1007/s11845-015-1246-0. Epub 2015 Jan 17
[PubMed PMID: 25595827]
[11]
Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017 Sep 12:318(10):918-926. doi: 10.1001/jama.2017.11470. Epub
[PubMed PMID: 28898379]
Level 1 (high-level) evidence